InsiderClue
Stocks · Health care · Pharmaceutical Preparations

SUPERNUS PHARMACEUTICALS, INC.

SUPN Clue Score33
United States Fiscal year ends December CIK 0001356576 Results filed 29 Oct 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

9
Insider
Date
Role
Action
Shares
Price
Amount
Jack A. Khattar
13 Mar 2026
President, CEO
Sold on a plan indirect
120
$51.75
$6.21K
Jack A. Khattar
13 Mar 2026
President, CEO
Sold on a plan indirect
10,742
$51.00
$547.84K
Jack A. Khattar
13 Mar 2026
President, CEO
Sold on a plan indirect
24,138
$50.09
$1.21M
Charles W Newhall III
9 Oct 2025
Director
Sold on a plan
1,200
$51.55
$61.86K
Charles W Newhall III
9 Oct 2025
Director
Sold on a plan
23,800
$50.73
$1.21M
Charles W Newhall III
27 Aug 2025
Director
Sold on a plan
3,588
$45.01
$161.50K
Charles W Newhall III
25 Aug 2025
Director
Sold on a plan
1,000
$45.00
$45.00K
Charles W Newhall III
22 Aug 2025
Director
Sold on a plan
1,412
$45.00
$63.54K
Bethany Sensenig
14 Aug 2025
Director
Sold on a plan
5,369
$42.25
$226.84K
Show all 165 transactions →

What was left out

Form 4 filings counted 394
Amendments (4/A) skipped 12
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 9
Sales straight out of an exercise 124
Sales at will 20
Transactions with no price 0
Shares from compensation/vesting 6,560,609
Sales filed before the plan box existed 11
History held since 7 May 2012